Climb Bio Inc. (CLYM)
NASDAQ: CLYMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 10.71 0.00%
CLYM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $615.14M
- EPS (TTM)
- -$0.82
- Dividend yield
- None
- 52-week range
- 1.64 – 18.33
- Day range
- 10.34 – 10.95
- Volume / Avg
- 755.81K / 1.39M
- Beta
- —
- Shares outstanding
- 57.44M
- Next earnings
- Nov 5, 2026
52-week range
CLYM stock today
On Oct 7, CLYM ended the session at $10.71, adding $0.03 (0.28%), versus the S&P 500's 0.22% decline. Shares are 41.6% below their 52-week high of $18.33, set on Aug 25, 2026 and 555.0% above the 52-week low of $1.64, in the middle of the past year's range. CLYM is up 167.8% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 549.1%.
Climb Bio has posted a net loss over the last twelve months (EPS of -$0.82), so its P/E ratio is not meaningful. Climb Bio's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Climb Bio
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Wellesley Hills, MA
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.19
Climb Bio peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SLNSilence Therapeutics Plc American Depository Share | 9.82 | -0.10% | $610.35M | vs CLYM |
| IRWDIronwood Pharmaceuticals Inc. Class A | 3.75 | +3.31% | $619.65M | vs CLYM |
| SGMTSagimet Biosciences Inc. Series A | 8.88 | +1.37% | $629.67M | vs CLYM |
| FTHFaeth Therapeutics Inc. | 24.92 | -7.33% | $643.94M | vs CLYM |
| AQSTAquestive Therapeutics Inc. | 4.62 | +0.22% | $579.86M | vs CLYM |
| EVOEvotec SE ADR | 1.61 | -1.23% | $572.18M | vs CLYM |
| ABUSArbutus Biopharma Corporation | 4.29 | -4.24% | $657.55M | vs CLYM |
| ZVRAZevra Therapeutics Inc. | 11.08 | +3.26% | $657.97M | vs CLYM |
Indexes, lists and sector
Largest Health Care stocks
Climb Bio stock FAQ
What is Climb Bio's stock price today?
CLYM last traded at $10.71 as of Oct 7, 4:00 PM EDT, up 0.28% on the day. Prices are delayed at least 15 minutes.
When is Climb Bio's next earnings date?
Climb Bio is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.19.
What is the CLYM 52-week high?
The 52-week high for CLYM is $18.33 and the 52-week low is $1.64. The stock is currently 41.6% below its high.